SUPREFACT INTRANASAL SOLUTION 1MG/ML
SUPREFACT INTRANASAL SOLUTION 1MG/ML
Discontinued
DIN Number
00680036
Drug Class
Human
Market Date
Dec 31, 1988
Company
HC
hoechst canada inc.
Product Information
Detailed information about this Health Canada approved drug product, including dosage form, route of administration, and regulatory classification.
Product Details
Health Canada regulatory and product classification information
Regulatory Identifiers
DIN Number00680036
AIG Number0131461001
Classification & Schedule
C
Drug Class
Human
S
Schedule
Prescription
A
ATC Code
L02AE01 BUSERELIN
Product Specifications
Dosage FormSpray
Route of AdministrationNasal
AHFS Classification92:00.00
Health Canada Classification
ACTIVE INGREDIENTS (1)
BUSERELIN ACETATEActive
Strength: 1 MG / ML
Monograph: BUSERELIN ACETATE